Zealand Pharma (ZEAL.CO) stock price, revenue, and financials

Zealand Pharma market cap is kr8.7 b, and annual revenue was kr234.8 m in FY 2016

KR8.7 B

ZEAL.CO Mkt cap, 10-Nov-2021

KR234.8 M

Zealand Pharma Revenue FY, 2016
Zealand Pharma Revenue growth (FY, 2015 - FY, 2016), %25%
Zealand Pharma Net income (FY, 2016)153.9 M
Zealand Pharma EBIT (FY, 2016)-115.7 M
Zealand Pharma Cash, 31-Dec-2016323.3 M
Get notified regarding key financial metrics and revenue changes at Zealand PharmaLearn more
Banner background

Zealand Pharma Income Statement

Annual

DKKFY, 2014FY, 2015FY, 2016

Revenue

153.8m187.7m234.8m

Revenue growth, %

22%25%

R&D expense

180.0m217.7m268.2m

General and administrative expense

39.8m41.8m52.5m

Operating expense total

233.6m281.8m352.2m

EBIT

(73.5m)(81.3m)(115.7m)

EBIT margin, %

(48%)(43%)(49%)

Interest expense

2.0m42.4m44.4m

Interest income

3.0m3.9m600.0k

Pre tax profit

72.5m119.8m159.4m

Income tax expense

7.5m5.9m5.5m

Net Income

65.0m114.0m153.9m

Quarterly

DKKQ1, 2015Q1, 2016

Revenue

6.0m6.7m

R&D expense

51.8m63.2m

General and administrative expense

75.0m8.0m

Operating expense total

127.6m72.1m

EBIT

(49.8m)(64.5m)

EBIT margin, %

(830%)(963%)

Interest expense

8.1m15.2m

Interest income

7.5m800.0k

Pre tax profit

54.3m78.9m

Income tax expense

1.1m1.1m

Net Income

53.2m77.8m

Zealand Pharma Balance Sheet

Annual

USDFY, 2014FY, 2015FY, 2016

Cash

516.8m418.8m323.3m

Accounts Receivable

25.0m158.2m11.5m

Prepaid Expenses

2.7m2.4m13.8m

Current Assets

575.4m617.1m373.2m

PP&E

17.6m15.8m13.2m

Total Assets

596.8m636.2m694.6m

Accounts Payable

18.5m21.7m19.7m

Current Liabilities

76.8m71.0m87.6m

Non-Current Liabilities

267.2m313.0m328.9m

Total Liabilities

343.9m384.0m416.4m

Additional Paid-in Capital

1.3b1.4b

Retained Earnings

229.6m(1.0b)(1.2b)

Total Equity

252.8m252.2m278.2m

Financial Leverage

2.4 x2.5 x2.5 x

Zealand Pharma Cash Flow

Annual

DKKFY, 2014FY, 2015FY, 2016

Net Income

(65.0m)(114.0m)(153.9m)

Cash From Operating Activities

(42.2m)(224.8m)40.9m

Purchases of PP&E

(4.5m)(4.0m)(2.6m)

Cash From Investing Activities

(1.7m)(1.6m)(300.0m)

Cash From Financing Activities

272.2m96.4m157.1m

Net Change in Cash

228.3m(129.9m)(101.9m)

Zealand Pharma Ratios

DKKFY, 2014

Financial Leverage

2.4 x

Zealand Pharma Operating Metrics

FY, 2016

Patents Issued

75

Patents Pending

19

Zealand Pharma Employee Rating

3.49 votes
Culture & Values
N/A
Work/Life Balance
N/A
Senior Management
N/A
Salary & Benefits
N/A
Career Opportunities
N/A
Source